texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

L. Andy Chen, M.D., is the Newest Physician to Join Texas Oncology


BEAUMONT, Texas – Dr. L. Andy Chen, a specialist in radiation oncology, has joined the cancer care team at Texas Oncology. He will practice at Texas Oncology–Beaumont and Texas Oncology–Jasper, two of Texas Oncology’s more than 150 cancer treatment locations in communities throughout Texas and southeastern Oklahoma.

Dr. Chen received his Bachelor of Arts degree from The University of Texas at Austin and his medical degree from the University of Texas Medical Branch in Galveston, Texas. Notably, he also obtained a Doctor of Philosophy, Biochemistry, and Molecular Biology from the University of Texas Medical Branch. He completed his internship in internal medicine at the University of Texas Medical Branch and his residency in radiation oncology at the University of Utah, Huntsman Cancer Hospital and Intermountain Medical Center in Salt Lake City, Utah, where he served as co-chief resident.

“At Texas Oncology, patients are provided leading-edge cancer care treatments and have access to national clinical trials,” said Dr. Chen. “I look forward to working with the Texas Oncology–Beaumont and Texas Oncology–Jasper teams as we lead the fight against cancer throughout the region.”

“Dr. Chen is a valuable addition to our medical team,” said Sammy Davis, practice administrator. His significant education and experience will benefit our patients and enhance the quality of care we provide.”

Texas Oncology–Beaumont and Jasper provide advanced radiation technologies and treatments. As a pioneer in community-based cancer care, Texas Oncology provides quality cancer care with advanced technologies in local communities where patients can stay near the critical support of family and friends. Patients have the opportunity to participate in some of the most promising national clinical trials, including radiation clinical trials, for a broad range of cancers. Texas Oncology, through its affiliation with US Oncology Research, has played a role in 50 FDA-approved cancer therapies, nearly one-third of all cancer therapies approved by the FDA to date.

Dr. Chen is a member of the American Brachytherapy Society, American College of Radiology, American Society of Clinical Oncology, and American Society for Radiation Oncology.


About Texas Oncology

As an independent oncology practice with more than 420 physicians and 175 locations, Texas Oncology’s community-based care offers patients high-quality cancer care without compromise, including access to leading-edge technology, advanced treatment options, and access to clinical trials. As a primary participant in US Oncology Research, Texas Oncology played a role in more than 70 FDA-approved therapies, about one-third of all cancer therapies approved by the agency to date.

Texas Center for Proton Therapy, Texas Breast Specialists, and Texas Center for Interventional Surgery are part of Texas Oncology. Texas Oncology is a member of The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks. For more information, visit www.TexasOncology.com.